en POLSKI
eISSN: 2084-9834
ISSN: 0034-6233
Reumatologia/Rheumatology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank


 
2/2009
vol. 47
 
Share:
Share:
more
 
 
abstract:
Case report

Skin melanoma in a rheumatoid arthritis patient treated with infliximab

Janusz Jaworski
,
Paula Śliwińska-Stańczyk
,
Jan Krzysztof Łącki

Reumatologia 2009; 47, 2: 98–100
Online publish date: 2009/06/10
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
We present a case of skin melanoma in a 53-year-old patient with rheumatoid arthritis (RA) treated with infliximab and methotrexate. After 12 months of therapy during a routine examination before infusion of infliximab, the enlarging pigmented naevus on the skin of the right arm was prophylactically removed. Histopathological evaluation and immunohistochemistry led to the diagnosis of skin melanoma. We suggest that systematic control of the pigmented naevus during anti-TNF therapy should be strongly recommended.
keywords:

infliximab, rheumatoid arthritis, melanoma







Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.